Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Uncover the potential of dupilumab in managing COPD patients with type 2 inflammation as this Phase 3 trial reveals fewer exacerbations, improved lung function, and enhanced life quality among the treated cohort.
Allergy & Immunology July 27th 2023
Medical Professionals Reference (MPR)
The FDA’s approval of Beyfortus offers a promising tool for RSV disease prevention in neonates and young children. This novel intervention, underscored by robust clinical trial data, marks a crucial stride towards protecting infant health in the US.
Pediatrics July 27th 2023
ACP Hospitalist
The new recommendations include continuing antiplatelet therapy for patients with a baseline indication for it, starting dual antiplatelet therapy for patients with confirmed ACS, and adding prophylactic-dose LMWH for patients on antiplatelet therapy for a previous stroke.
Cardiology July 12th 2023
American Thoracic Society
Examine the case of a young smoker with acute dyspnea whose chest CT reveals oddly shaped cysts to uncover a mystery that goes beyond usual diagnostics and leads us into the world of uncommon lung disorders.
Pulmonology June 22nd 2023
Oncology News Central (ONC)
A deeper understanding of the impact of smoking and vaping on cancer survivor symptom burdens might open new avenues for tailoring smoking cessation interventions. Uncover how these findings could challenge common assumptions and transform symptom management strategies in our recent article.
Cardiology June 20th 2023
ACP Internist
Get ready to reassess what you thought you knew about over-the-counter decongestants. Discover how patient reviews, clinical evidence, and a better understanding of these medications can transform your approach.
Allergy & Immunology June 14th 2023